Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
29.82
-0.03 (-0.10%)
Apr 21, 2026, 3:00 PM CST

SHA:688319 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,11010,2944,3036,4175,62114,513
Market Cap Growth
113.71%139.25%-32.95%14.17%-61.27%-
Enterprise Value
12,29510,4824,4226,2675,42014,115
Last Close Price
29.8525.3610.6015.7413.8135.67
PE Ratio
544.04462.46207.29365.54211.50134.42
Forward PE
165.83187.8598.6160.7738.4459.68
PS Ratio
17.2014.627.3112.9410.2729.79
PB Ratio
13.4011.394.616.906.3017.18
P/TBV Ratio
13.6611.614.747.136.5117.47
P/FCF Ratio
1812.291540.54----
P/OCF Ratio
114.8097.58-145.85-363.16
EV/Sales Ratio
17.4614.897.5112.639.9028.97
EV/EBITDA Ratio
174.50158.3487.75204.71135.49120.71
EV/EBIT Ratio
-320.25204.541787.91368.70150.33
EV/FCF Ratio
1839.841568.66----
Debt / Equity Ratio
0.480.480.390.260.150.05
Debt / EBITDA Ratio
6.156.156.696.933.350.33
Debt / FCF Ratio
64.8064.80----
Net Debt / Equity Ratio
0.200.200.13-0.13-0.25-0.49
Net Debt / EBITDA Ratio
2.782.782.38-4.07-5.63-3.56
Net Debt / FCF Ratio
27.5127.51-0.550.991.0013.99
Asset Turnover
0.370.370.340.320.410.53
Inventory Turnover
0.850.850.380.490.560.47
Quick Ratio
1.231.231.371.801.632.34
Current Ratio
1.351.351.531.961.782.56
Return on Equity (ROE)
2.38%2.38%1.69%1.26%3.06%17.68%
Return on Assets (ROA)
1.07%1.07%0.79%0.14%0.68%6.33%
Return on Invested Capital (ROIC)
2.01%2.10%1.64%0.35%1.63%26.12%
Return on Capital Employed (ROCE)
2.50%2.50%1.80%0.30%1.50%10.80%
Earnings Yield
0.18%0.22%0.48%0.27%0.47%0.74%
FCF Yield
0.06%0.07%-5.04%-1.96%-4.01%-0.21%
Dividend Yield
---0.24%--
Payout Ratio
66.11%66.11%142.97%34.11%16.00%0.95%
Buyback Yield / Dilution
-0.01%-0.01%0.01%-0.07%-5.22%-5.61%
Total Shareholder Return
-0.01%-0.01%0.01%0.17%-5.22%-5.61%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.